These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 17285118)
1. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma. Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118 [TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma. Tsuboi K; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Kato H; Kuwano H Cancer Lett; 2004 Mar; 205(2):207-14. PubMed ID: 15036653 [TBL] [Abstract][Full Text] [Related]
3. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Oka M; Yamamoto K; Takahashi M; Hakozaki M; Abe T; Iizuka N; Hazama S; Hirazawa K; Hayashi H; Tangoku A; Hirose K; Ishihara T; Suzuki T Cancer Res; 1996 Jun; 56(12):2776-80. PubMed ID: 8665513 [TBL] [Abstract][Full Text] [Related]
4. Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma. Duan L; Ye L; Zhao G; Wu Z; Jin C; Cai X; Li G Eur J Cardiothorac Surg; 2013 Mar; 43(3):e58-63. PubMed ID: 23242981 [TBL] [Abstract][Full Text] [Related]
5. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus. Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976 [TBL] [Abstract][Full Text] [Related]
6. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Wang LS; Chow KC; Wu CW Br J Cancer; 1999 Jul; 80(10):1617-22. PubMed ID: 10408408 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma. Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976 [TBL] [Abstract][Full Text] [Related]
8. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351 [TBL] [Abstract][Full Text] [Related]
11. Identification of the peripheral blood levels of interleukin-12, interleukin-10, and transforming growth factor-β in patients with laryngeal squamous cell carcinoma. Günaydın RÖ; Kesikli SA; Kansu E; Hoşal AŞ Head Neck; 2012 Mar; 34(3):393-7. PubMed ID: 21472884 [TBL] [Abstract][Full Text] [Related]
12. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593 [TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin levels in patients with esophageal cancer. Yildirim A; Bilici M; Cayir K; Yanmaz V; Yildirim S; Tekin SB Jpn J Clin Oncol; 2009 Feb; 39(2):92-6. PubMed ID: 19116211 [TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers in head and neck squamous cell cancer. Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368 [TBL] [Abstract][Full Text] [Related]
15. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients. Shimada Y; Maeda M; Watanabe G; Imamura M Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758 [TBL] [Abstract][Full Text] [Related]
16. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma. Nabeya Y; Shimada H; Okazumi S; Matsubara H; Gunji Y; Suzuki T; Ochiai T Cancer; 2002 Feb; 94(4):940-9. PubMed ID: 11920462 [TBL] [Abstract][Full Text] [Related]
17. Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas. Liu P; Chen S; Wu W; Liu B; Shen W; Wang F; He X; Zhang S Jpn J Clin Oncol; 2012 Jul; 42(7):612-8. PubMed ID: 22581910 [TBL] [Abstract][Full Text] [Related]
19. [Postoperative Th1 and Th2 type cytokine changes in patients with esophageal squamous cell carcinoma and their clinical significance]. Wei YC; Hu FB; Shen Y; Xu LH; Lin LS Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1271-3. PubMed ID: 15567776 [TBL] [Abstract][Full Text] [Related]